Almas Babar, Ph.D. R.Ph.
Professor, Industrial Pharmacy and Cosmetic Sciences
Ph.D., St. John’s University, New York, NY, in Industrial Pharmacy
M.S., St. John’s University, New York, NY, in Industrial Pharmacy
B.S. Pharmacy, University of Punjab, Lahore, Pakistan
Specialized Training: Aerosol Science & Technology (Dupont Co., Inc.)
Dr. Babar received his B.S. degree in Pharmacy from the University of Punjab, Lahore and graduated as a university scholar. Later, he had the honor of joining Dr. John J. Sciarra as a graduate student, and received his M.S. degree in Aerosol Science & Technology and Ph.D. with specialization in biopharmaceutics /pharmacokinetics from the St. John’s University, New York. Prior to joining the faculty at LIU, he worked in the industry specializing in product formulations R&D and developed several state-of-the-art products in the area of dermatology, nasal, hair care and aerosolized drug delivery systems. He is the proud member of the first scientific R&D team in the USA to introduce the concept of protein coatings on the human hair (Protein-21) and NMF’s based skin-care products. He has developed many consumer products for Richardson/Merrell, J&J, Estee Lauder, Loreal of Paris, Alfred Dunhill and many other national and international companies. Later, his passion grew into developing high efficacy topical and TDDS products to deliver potent drugs like Testostrone, Prixoicam and Diclofenac sodium etc. As a researcher, his special interests are to optimize the clinical efficacy of both the oral and dermatological pharmaceutical products with reduced levels of the API’s. Today, Dr. Babar is considered as one of the authorities in the fields of dermatological and aerosol drug delivery systems. Dr. Babar teaches pharmaceutics and specialized graduate courses in the areas of industrial pharmacy, dermatologicals, cosmeceuticals, novel drug delivery systems and aerosol science & technology. Dr. Babar has served as the Program Director for the graduate programs for both Industrial Pharmacy and Cosmetic Science at the Westchester branch of the university (1985- 2005). Also, he has organized, chaired and directed industrial symposiums and is very proud to have presented papers along with the top Ivy league educator and researchers including Dr. Albert Kligman, the inventor of the Retin-A line of products. Dr. Babar is a registered pharmacist in the states of New York, New Jersey and Maryland. He is an active member of several prestigious national and international scientific organizations throughout the world.
Dr. Babar’s research interests are diverse and mainly focused in the areas of product formulation and optimization of clinical efficacy of oral, dermatological and aerosolized drug delivery systems. The research emphases are on the development and evaluations of nanoparticles and high-energy solid dispersions for the enhancement of drug dissolution and bioavailability of the hydrophobic drug molecules. Other areas include new technique to develop multiple strengths CR dosage forms of drugs using a single solid powder formulation to minimize overall R&D work. Moreover, as a researcher, his passion is to optimize and develop “state-of-the-art” dermatological formulations with enhanced drug release and clinical efficacy even with the reduced level of drugs. His work strongly supports that “Less is More” when it comes to dermatological pharmaceutical products.
- Z. Iqbal, A. Babar and M. Ashraf, “Controlled- Release Naproxen Using Micronized Ethyl Cellulose by Wet-Granulation and Solid- Dispersion Method,” Drug Dev Ind Pharm (28) 2,129-134 (2002) http://www.ncbi.nlm.nih.gov/pubmed/11926356
- Babar, S.D. Ray, N. Patel, F.M. Plakogiannis and P. Gogineni, “In Vitro Release and Diffusion Studies of Promethazine Hydrochloride from Polymeric Dermatological Bases Using Cellulose Membrane and Hairless Mouse Skin,” Drug Dev Ind Pharm 25(2) 235-240 (1999) http://www.ncbi.nlm.nih.gov/pubmed/10065358
- Babar, T. Bellette and F.M. Plakogiannis, “Ketoprofen Suppository Dosage Forms: In-Vitro Release and In-Vivo Absorption Studies in Rabbits,” Drug Dev Ind Pharm 25(2) 241-245 (1999) http://www.ncbi.nlm.nih.gov/pubmed/10065359
- Babar, A., Fares, H. and Plakogiannis, F.M., “Suppository Dosage Forms of Testosterone with Reduced Presystemic Inactivation”, J Pharm Sci 83 (4) 389-391, (1993) http://www.ncbi.nlm.nih.gov/pubmed/8468682
- Babar, A., Pillai, J.C. and Plakogiannis, F.M., “In-vitro Release of Propanolol Hydrochloride from Polymeric Gels Using Hairless Mouse Skin”, Drug Dev Ind Pharm 18(16) 1823-30 (1992).
- Babar, A., Bhandari, R.D. and Plakogiannis, F.M., “In-vitro Release Studies of Chlorpheniramine Maleate from Topical Bases Using Cellulose Membrane and Hairless Mouse Skin”, Drug Dev Ind Pharm 17(16), 2145-56, (1991).
- Babar, A., Chikhale, P.J. and Plakogiannis, F.M., “Assessment of Triethanolamine Salicylate Release from Dermatological Bases and the Commercial Products”, Pharm Acta Helv 66 (12) 322-328, (1991) http://www.ncbi.nlm.nih.gov/pubmed/1784579
- Babar, A., U.D., Cutie, A.J. and Plakogiannis, F.M., Medicament Release from Dermatological Bases Using Cellulose Membrane and Hairless Mouse Skin”, Drug Dev Ind Pharm 16(3) 523-540, (1990).
- Rahman, M.S., Babar, A., Patel, N.K. and Plakogiannis, F.M., Medicament Release from Ointment Bases and the In-Vivo Percutaneous Absorption in Rabbits”, Drug Dev Ind Pharm 16(4) 651-72, (1990).
- Babar, A., Raouf, M. and Plakogiannis, F.M., “In-vitro Release Studies of Methyl Salicylate from the Ointment Bases and the Commercial Dermatological Products”, Pharm Acta Helv 65(5-6) 170-174, (1990). http://www.ncbi.nlm.nih.gov/pubmed/2371308
- Patel, N.K., Poola, N.R. Babar, A. and Plakogiannis, F.M., “Fluidized-Bed Agglomeration of Acetaminophen: Direct Compression of Tablets and Physiological Activity in Human”, Drug Dev Ind Pharm 15(8) 1175-98, (1989).
- Babar, A., Khaleque, R.A., Cutie, A.J. and Plakogiannis, F.M., “Diadermatic Dosage Forms of Testosterone: In vitro Release Studies and In-Vivo Absorption in Human Male”, Drug Dev Ind Pharm 15(9), 1405-22, (1989).
- Babar, A., Kaachy, A., Cutie, A.J. and Plakogiannis, F.M., “Gas Chromatography Methods for Simultaneous Analysis of Urinary Testosterone, Androsterone and Etiocholanolone: Determinations After a Single Dose of Testosterone”, Pharm Acta Helv 6 (9-10):278-81, (1988) http://www.ncbi.nlm.nih.gov/pubmed/3237733
- Plakogiannis, F.M., Mazouf, S.Z. and Babar, A., “Determination of the Optimum Solvent Systems for Extraction of Minoxidil from a Tablet Dosage Form”, Pharm Acta Helv 64(12) 348-50, (1989) http://www.ncbi.nlm.nih.gov/pubmed/2616584
- Pillai, J.C., Babar, A., Plakogiannis, F.M., “Polymers in Cosmetic and Pharmaceutical Industries”, Pharm Acta Helv 63 (2) 46-53, (1988) http://www.ncbi.nlm.nih.gov/pubmed/3287393
- Muktadir, A., Babar, A., and Plakogiannis, F.M., “Medicament Release from Ointment Bases, Ibuprofen: In-Vitro Release and In-Vivo Absorption in Rabbits”, Drug Dev Ind Pharm 12(14) 2521-40, (1986).
- Parikh, N.H., Babar, A. and Plakogiannis, F.M., “In-Vitro Release of Testosterone from Ointment Bases and the Effects of Additives on the Release Rate”, Drug Dev Ind Pharm 12(14), 2493-2509, (1986).
- Babar, A., Kawilarang, C. and Plakogiannis, F.M., “In-Vitro Release of Zinc Pyrithione from the Shampoo Base and the Effects of Additives on the Release Rate”, Drug Dev Ind Pharm 11(8), 1507-22, (1985).
- Parikh, N.H., Babar, A. and Plakogiannis, F.M., “Transdermal, F.M., Therapeutic Systems, Part II, Pharm Acta Helv 60(2) 34-38, (1985). http://www.ncbi.nlm.nih.gov/pubmed/3921987
- Parikh, N.H., Babar, A. and Plakogiannis, F.M., “Transdermal Therapeutic Systems, Part I, Pharm Acta Helv 59(11) 290-92, (1984). http://www.ncbi.nlm.nih.gov/pubmed/6514757
- Babar, A., and Jarowski, C.I., Solid Dispersions of Testosterone with Reduced Presystemic Inactivation,” J Pharm Sci 72 (6) 708-10, (1983). http://www.ncbi.nlm.nih.gov/pubmed/6875838